Martínez-Bonet M, Clemente MI, Serramía MJ, Moreno S, Muñoz E, Muñoz-Fernández MA.

Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells::a possibility for HIV-1 paediatric patients?

Journal of virus eradication 2015. 1(3): 148-152. Number of citations: 4

May MT, Justice AC, Birnie K, Ingle SM, Smit C, Smith C, Neau D, Guiguet M, Schwarze-Zander C, Moreno S, Guest JL, Monforte Ad, Tural C, Gill MJ, Bregenzer A, Kirk O, Saag M, Sterling TR, Crane HM, Sterne JA.

Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2015. 69(3): 348-354. Number of citations: 34

[doi:10.1097/QAI.0000000000000603]

Arribas JR, Girard PM, Landman R, Pich J, Mallolas J, Martínez-Rebollar M, Zamora FX, Estrada V, Crespo M, Podzamczer D, Portilla J, Dronda F, Iribarren JA, Domingo P, Pulido F, Montero M, Knobel H, Cabié A, Weiss L, Gatell JM, OLE/RIS-EST13 Study Group.

Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

LANCET INFECTIOUS DISEASES 2015. 15(7): 785-792. Number of citations: 121

[doi:10.1016/S1473-3099(15)00096-1]

Aldámiz-Echevarría T, González-García J, Von Wichmann MA, Crespo M, López-Aldeguer J, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Bellón JM, Montes M, Berenguer J.

Association of baseline CD4+cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients

ANNALS OF HEPATOLOGY 2015. 14(4): 464-469. Number of citations: 1

[doi:10.1016/S1665-2681(19)31167-6]

Perez-Molina JA, Rubio R, Rivero A, Pasquau J, Suárez-Lozano I, Riera M, Estébanez M, Santos J, Sanz-Moreno J, Troya J, Mariño A, Antela A, Navarro J, Esteban H, Moreno S.

Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

LANCET INFECTIOUS DISEASES 2015. 15(7): 775-784. Number of citations: 103

[doi:10.1016/S1473-3099(15)00097-3]

Norman FF, Monge-Maillo B, Perez-Molina JA, de Ory F, Franco L, Sánchez-Seco MP, López-Vélez R.

Lymphadenopathy in Patients With Chikungunya Virus Infection Imported From Hispaniola: Case Reports

JOURNAL OF TRAVEL MEDICINE 2015. 22(4): 272-275. Number of citations: 3

[doi:10.1111/jtm.12204]

Abad-Fernández M, Dronda F, Moreno A, Casado JL, Pérez-Elías MJ, Quereda C, Moreno S, Vallejo A.

Reduced Cell-Associated HTLV-2 DNA in Antiretroviral Treated HIV-1-HCV-Coinfected Patients Who Either Received Interferon-alpha/Ribavirin-Based Hepatitis C Therapy or Had Spontaneous HCV RNA Clearance

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2015. 69(3): 286-290. Number of citations: 3

[doi:10.1097/QAI.0000000000000608]

Vázquez-Castellanos JF, Serrano-Villar S, Latorre A, Artacho A, Ferrús ML, Madrid N, Vallejo A, Sainz T, Martínez-Botas J, Ferrando-Martínez S, Vera M, Dronda F, Leal M, Del Romero J, Moreno S, Estrada V, Gosalbes MJ, Moya A.

Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals

MUCOSAL IMMUNOLOGY 2015. 8(4): 760-772. Number of citations: 179

[doi:10.1038/mi.2014.107]

Boggild AK, Esposito DH, Kozarsky PE, Ansdell V, Beeching NJ, Campion D, Castelli F, Caumes E, Chappuis F, Cramer JP, Gkrania-Klotsas E, Grobusch MP, Hagmann SH, Hynes NA, Lim PL, López-Vélez R, Malvy DJ, Mendelson M, Parola P, Sotir MJ, Wu HM, Hamer DH, GeoSentinel Surveillance Network.

Differential Diagnosis of Illness in Travelers Arriving From Sierra Leone, Liberia, or Guinea: A Cross-sectional Study From the GeoSentinel Surveillance Network

ANNALS OF INTERNAL MEDICINE 2015. 162(11): 757-764. Number of citations: 31

[doi:10.7326/M15-0074]

Brunetta J, Moreno Guillén S, Antinori A, Yeni P, Wade B, Johnson M, Shalit P, Ebrahimi R, Johnson B, Walker I, De-Oertel S.

Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial.

PATIENT-PATIENT CENTERED OUTCOMES RESEARCH 2015. 8(3): 257-267. Number of citations: 13

[doi:10.1007/s40271-015-0123-2]

Torre-Cisneros J, San-Juan R, Rosso-Fernández CM, Silva JT, Muñoz-Sanz A, Muñoz P, Miguez E, Martín-Dávila P, López-Ruz MA, Vidal E, Cordero E, Montejo M, Blanes M, Fariñas MC, Herrero JI, Rodrigo J, Aguado JM.

Tuberculosis Prophylaxis With Levofloxacin in Liver Transplant Patients Is Associated With a High Incidence of Tenosynovitis: Safety Analysis of a Multicenter Randomized Trial

CLINICAL INFECTIOUS DISEASES 2015. 60(11): 1642-1649. Number of citations: 36

[doi:10.1093/cid/civ156]

Bañón S, Rosillo M, Gómez A, Pérez-Elias MJ, Moreno S, Casado JL.

Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients

Endocrine 2015. 49(2): 528-537. Number of citations: 16

[doi:10.1007/s12020-014-0489-2]

Rodríguez-Baño J, Cisneros JM, Cobos-Trigueros N, Fresco G, Navarro-San Francisco C, Gudiol C, Horcajada JP, López-Cerero L, Martínez JA, Molina J, Montero M, Paño-Pardo JR, Pascual A, Peña C, Pintado V, Retamar P, Tomás M, Borges-Sa M, Garnacho-Montero J, Bou G.

Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2015. 33(5): 338-341. Number of citations: 8

[doi:10.1016/j.eimc.2014.11.015]

Rodríguez-Baño J, Cisneros JM, Cobos-Trigueros N, Fresco G, Navarro-San Francisco C, Gudiol C, Horcajada JP, López-Cerero L, Martínez JA, Molina J, Montero M, Paño-Pardo JR, Pascual A, Peña C, Pintado V, Retamar P, Tomás M, Borges-Sa M, Garnacho-Montero J, Bou G.

Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2015. 33(5): 337-337. Number of citations: 18

[doi:10.1016/j.eimc.2014.11.009]

Puig-Asensio M, Ruiz-Camps I, Fernández-Ruiz M, Aguado JM, Muñoz P, Valerio M, Delgado-Iribarren A, Merino P, Bereciartua E, Fortún J, Cuenca-Estrella M, Almirante B, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI.

Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2015. 21(5): .

[doi:10.1016/j.cmi.2014.12.027]

Monge-Maillo B, López-Vélez R.

Miltefosine for Visceral and Cutaneous Leishmaniasis: Drug Characteristics and Evidence-Based Treatment Recommendations

CLINICAL INFECTIOUS DISEASES 2015. 60(9): 1398-1404. Number of citations: 46

[doi:10.1093/cid/civ004]

Sánchez-Montalvá A, Martínez-Pérez Á, Pérez-Molina JA, González-López JJ, Lopez-Vélez R, Salvador F, Sánchez I, Planes AM, Molina I.

Clinical and Microbiological Profile of a Retrospective Cohort of Enteric Fever in 2 Spanish Tertiary Hospitals

Medicine 2015. 94(21): . Number of citations: 2

[doi:10.1097/MD.0000000000000791]

Serrano-Villar S, Sobrino-Vegas P, Monge S, Dronda F, Hernando A, Montero M, Viciana P, Clotet B, Pineda JA, Del Amo J, Moreno S.

Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain

JOURNAL OF VIRAL HEPATITIS 2015. 22(5): 496-503. Number of citations: 13

[doi:10.1111/jvh.12353]